The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso

Autor: Rosemonde M. Guissou, Chanaki Amaratunga, Freek de Haan, Fatoumata Tou, Phaik Yeong Cheah, R. Serge Yerbanga, Ellen H. M. Moors, Mehul Dhorda, Paulina Tindana, Wouter P. C. Boon, Arjen M. Dondorp, Jean Bosco Ouédraogo

Publikováno v: Malaria Journal, Vol 22, Iss 1, Pp 1-14 (2023)

Abstract Background Widespread artemisinin resistance in Africa could be catastrophic when drawing parallels with the failure of chloroquine in the 1970s and 1980s. This article explores the role of anti-malarial market characteristics in the emergen

Externí odkaz: https://doaj.org/article/a2100af6ffaa48bcbff4f59add2c82ee

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

Autor: Olugbenga Ayodeji Mokuolu, Oladimeji Akeem Bolarinwa, Oluwatumobi Racheal Opadiran, Hafsat Abolore Ameen, Mehul Dhorda, Phaik Yeong Cheah, Chanaki Amaratunga, Freek de Haan, Paulina Tindana, Arjen M. Dondorp

Publikováno v: Malaria Journal, Vol 22, Iss 1, Pp 1-13 (2023)

Abstract Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are worrisome and suggest a future policy change to adopt new anti-malarials. This is a case study on the evolution, adoption, and implementation of new anti-

Externí odkaz: https://doaj.org/article/29e39db799f94f25b9418b998918a5a1

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

Autor: Paulina Tindana, Freek de Haan, Chanaki Amaratunga, Mehul Dhorda, Rob W. van der Pluijm, Arjen M. Dondorp, Phaik Yeong Cheah

Publikováno v: Malaria Journal, Vol 20, Iss 1, Pp 1-7 (2021)

Abstract Malaria remains a major cause of morbidity and mortality in Africa, particularly in children under five years of age. Availability of effective anti-malarial drug treatment is a cornerstone for malaria control and eventual malaria eliminatio

Externí odkaz: https://doaj.org/article/373dc6e418ec419dbdb510e2c5cde0a6

Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol. [version 1; peer review: 2 approved]

Autor: Paulina Tindana, Freek de Haan, Olugbenga Ayodeji Mokuolu, Rosemonde Guissou, Oladimeji Akeem Bolarinwa, Jean Bosco Ouedraogo, Fatoumata Tou, Wouter P.C Boon, Ellen H.M Moors, Arjen M Dondorp, Mehul Dhorda, Chanaki Amaratunga, Phaik Yeong Cheah

Publikováno v: Wellcome Open Research, Vol 6 (2021)

Introduction: According to the World Malaria Report 2019, Africa accounts for 94% of the global malaria deaths. While malaria prevalence and mortality have declined over the years, recent reports suggest that these gains may stand the risk of being r

Externí odkaz: https://doaj.org/article/e524aa6a6bbc49e395ad31f7de1311a8

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

Autor: Wouter Boon, Mehul Dhorda, Arjen M. Dondorp, Olugbenga A. Mokuolu, Phaik Yeong Cheah, Freek de Haan, Rosemonde Guissou, Paulina Tindana, Jean-Bosco Ouédraogo, Ellen H.M. Moors, Chanaki Amaratunga, Fatoumata Tou, Oladimeji Akeem Bolarinwa

Publikováno v: PLoS One, 16(8), 1. Public Library of Science
PLoS ONE, Vol 16, Iss 8, p e0256567 (2021)
PLoS ONE
PLoS ONE, 16(8 August):e0256567. Public Library of Science

Introduction Triple artemisinin-based combination therapies (TACTs) are being developed as a response to artemisinin and partner drug resistance in the treatment of falciparum malaria in Southeast Asia. In African countries, where current artemisinin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc38677ab8603147ca415c97f75d0fc3
https://dspace.library.uu.nl/handle/1874/412946